S S Taneja

Summary

Affiliation: New York University
Country: USA

Publications

  1. ncbi request reprint Androgen stimulated cellular proliferation in the human prostate cancer cell line LNCaP is associated with reduced retinoblastoma protein expression
    S S Taneja
    Department of Urology, The Kaplan Comprehensive Cancer Center, New York University School of Medicine, New York, New York 10016, USA
    J Cell Biochem 84:188-99. 2001
  2. pmc Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer
    S Ha
    Department of Urology, New York University School of Medicine, New York, NY 10016, USA
    Oncogene 32:3992-4000. 2013
  3. ncbi request reprint Impact of race on survival of prostate cancer patients treated with noncurative intent
    D Hatcher
    New York University School of Medicine, New York, NY Weill Cornell Medical College, New York, NY
    J Clin Oncol 27:5069. 2009

Collaborators

  • W L Gerald
  • H Lepor
  • S Ha
  • P Lee
  • D Hatcher
  • R Ruoff
  • S K Logan
  • J Melamed
  • N J Iqbal
  • P Mita
  • M J Garabedian
  • P J Christos
  • M John
  • A E Rose
  • I Osman
  • M Mazumdar

Detail Information

Publications3

  1. ncbi request reprint Androgen stimulated cellular proliferation in the human prostate cancer cell line LNCaP is associated with reduced retinoblastoma protein expression
    S S Taneja
    Department of Urology, The Kaplan Comprehensive Cancer Center, New York University School of Medicine, New York, New York 10016, USA
    J Cell Biochem 84:188-99. 2001
    ..We propose that the observed reduction in Rb protein level occurs through Rb degradation via the ubiquitin/proteasome pathway, and is preceded by selective Rb phosphorylation by cyclin A/Cdk2 and cyclin B/Cdk1...
  2. pmc Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer
    S Ha
    Department of Urology, New York University School of Medicine, New York, NY 10016, USA
    Oncogene 32:3992-4000. 2013
    ..Thus, AR phosphorylation by PIM1 at S213 impacts gene transcription and is highly prevalent in aggressive prostate cancer...
  3. ncbi request reprint Impact of race on survival of prostate cancer patients treated with noncurative intent
    D Hatcher
    New York University School of Medicine, New York, NY Weill Cornell Medical College, New York, NY
    J Clin Oncol 27:5069. 2009
    ..We hypothesized that comparing patients whose PC was not altered by primary treatment might give a better idea about the difference, if any, of the natural history of PC in AA compared to CA patients...